Open Access
Table 3
Characteristic of participants enrolled and completing follow-up, Madagascar 2018.
| Farafangana | Mananjary | |||
|---|---|---|---|---|
|
|
||||
| ASAQ, n = 89 | AL, n = 87 | ASAQ, n = 84 | AL, n = 87 | |
| Crude results | ||||
| Early treatment failure, n (%) | 0 | 0 | 0 | 2 (2.2) |
| Late clinical failure, n (%) | 0 | 1 (1.2%) | 0 | 1 (1.1) |
| Late parasitological failure, n (%) | 0 | 1 (1.2%) | 0 | 2 (2.2) |
| RCPA | 89 (100%) | 85 (97.7%) | 84 (100%) | 82 (94.3%) |
| Corrected results | ||||
| Early treatment failure, n | 0 | 0 | 0 | 2 |
| Recrudescence, n | 0 | 1 | 0 | 1 |
| Day 21 | 0 | 1 | 0 | 1 |
| Day 28 | 0 | 0 | 0 | 0 |
| Reinfection, n | 0 | 1 | 0 | 2 |
| Day 21 | 0 | 0 | 0 | 0 |
| Day 28 | 0 | 1 | 0 | 2 |
| RCPA | 89 (100%) | 85 (98.8%) | 84 (100%) | 82 (96.5%) |
| Hemoglobin day 0 (g/dL), median (IIQ) | 10 (9.2–11.3) | 10.2 (9–11.2) | 11.7 (10.3–13) | 11.7 (10.1–13.2) |
| Hemoglobin day 28 (g/dL), median (IIQ) | 10.6 (8.2–11.6) | 11.6 (10.6–12.6) | 12.2 (11.3–13.3) | 12.4 (11.2–13.6) |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.